Most likely you, or one of your patients, was recently diagnosed with NET. NET is rare, and every NET is different. It is so infrequent that a GP on average only sees 1 or 2 patients with this form of cancer during his career.
For a PRRT treatment with good results, it is important that you go to a specialist with experience in treating NET patients.
For a visual overview of the different steps before, during and after treatment, view the following schematic representations:
Requirements PRRT Treatment
Patients with somatostatin receptor positive tumors can in principle be treated with PRRT. Most often these patients have a neuroendocrine tumor (NET). Most patients have a NET of the small intestine (carcinoid) or of the pancreas.
PRRT treatment is primarily used to treat metastasized or inoperable grade 1 or grade 2 (relatively slow growing) tumors. Grade 3 tumors are generally treated with chemotherapy. Read more about the treatment or about the grading of NETs.
Indications to start with PRRT
A waiting approach is often best the best approach for patients with NET. The indications for starting PRRT treatment are progression of the disease, high tumor burden/load and a symptoms that cannot be managed by medication. In some cases where the pancreas cannot be operated upon, PRRT can be applied in a neoadjuvant setting, hopefully leading to a decreased tumor size so that surgery is possible.
Find more information about: